These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5990815)

  • 1. [On the possible role of serotonin (5-HT) in the origin of the cutaneous Sanarelli-Shwartzman phenomenon].
    Musumeci V
    Minerva Dermatol; 1966 Jun; 41(6):193-9. PubMed ID: 5990815
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the participation of circulating fibrinogen in the determination of the cutaneous Sanarelli-Shwartzman phenomenon. Experimental investigations on animals poisoned with aniline or treated with streptokinase].
    Musumeci V
    Minerva Dermatol; 1966 May; 41(5):145-9. PubMed ID: 5945662
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Sanarelli-Shwartzman phenomenon in the animal experiment].
    Krecke HJ
    Dtsch Med J; 1967 Jun; 18(11):355-9. PubMed ID: 5607430
    [No Abstract]   [Full Text] [Related]  

  • 4. [On vasal permeability of the skin, seat of the Sanarelli-Shwartzman phenomenon. (Experimental research)].
    Musumeci V
    Folia Allergol (Roma); 1966; 13(2):119-26. PubMed ID: 5914221
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the Shwartzman-Sanarelli phenomenon].
    Oswald J; Oswald W
    Allerg Asthma (Leipz); 1967; 13(5):231-6. PubMed ID: 5594744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical manifestation of the Sanarelli-Shwartzman phenomenon in dermatology. I. Herpes zoster generalisatus and the Sanarelli-Shwartzman phenomenon].
    RICHTER R; JOHNE HO
    Z Haut Geschlechtskr; 1950 May; 8(9):333-42. PubMed ID: 15431793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical manifestations of the Sanarelli-Shwartzman phenomenon in dermatology; acute febrile pemphigus and related diseases, and postoperative gangrene as manifestations of the Sanarelli-Shwartzman phenomenon].
    RICHTER R
    Arch Dermatol Syph; 1950; 190(4):317-40. PubMed ID: 15433262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on pharmacological modification of the localized Sanarelli-Shwartzman phenomenon].
    Haustein KO; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):104-8. PubMed ID: 4114578
    [No Abstract]   [Full Text] [Related]  

  • 9. [BLOOD LIPIDS AND INTRAVASCULAR COAGULATION IN THE PATHOGENESIS OF THE SANARELLI-SHWARTZMAN PHENOMENON].
    MUELLER-BERGHAUS G; HUTH K; KRECKE HJ; LASCH HG
    Schweiz Med Wochenschr; 1964 Oct; 94():1519-26. PubMed ID: 14318347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rheologic properties of blood in the Sanarelli--Shwartzman penomenon].
    Balashov LD
    Patol Fiziol Eksp Ter; 1979; (4):20-3. PubMed ID: 481915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the problem of blood coagulation disorder in the Sanarelli-Shwartzman phenomena (so-called generalized Shwartzman phenomenon) of the rabbit].
    KLEINMAIER H; GOERGEN K; LASCH HG; KRECKE HJ; BOHLE A
    Z Gesamte Exp Med; 1959; 132():275-94. PubMed ID: 14409739
    [No Abstract]   [Full Text] [Related]  

  • 12. [CHANGES OF FREE THROMBOCYTE NUCLEOTIDES IN THE SANARELLI-SHWARTZMAN PHENOMENON].
    WEBER E; MALESSA S; LASCH HG
    Thromb Diath Haemorrh; 1963 Jul; 143():304-16. PubMed ID: 14081254
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of streptokinase on the Sanarelli-Shwartzman phenomenon of the rabbit].
    Junge WD; Stark KH
    Z Geburtshilfe Gynakol; 1968; 169(3):320-9. PubMed ID: 4885434
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE SANARELLI-SHWARTZMAN LOCAL PHENOMENON. I. INFLUENCE OF AN ASSOCIATION OF TRYPSIN, CHYMOTRYPSIN AND "TRIPSEPAR"].
    D AMICO G
    G Ital Chir; 1964 Mar; 20():191-217. PubMed ID: 14203868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of experimental endotoxin shock. I. Comparative morphologic findings following endotoxin shock in Sanarelli-Shwartzman phenomenon].
    Hoppe E; Dieckhoff J; Bartel J
    Padiatr Grenzgeb; 1968; 7(1):37-46. PubMed ID: 5715856
    [No Abstract]   [Full Text] [Related]  

  • 16. [Induction of a generalized Sanarelli-Shwartzman reaction in spite of extreme granulocytopenia after nitrogenmustard].
    Wendt F; Kappler C; Burckhardt K; Bohle A
    Verh Dtsch Ges Inn Med; 1967; 73():361-5. PubMed ID: 5591776
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of the mechanism o f the Sanarelli-Shwartzman phenomenon in pathogenesis].
    KISS L
    Rev Tuberc Pneumol (Paris); 1963; 27():323-5. PubMed ID: 14033098
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Sanarelli-Shwartzman phenomenon in the light of modern research. II].
    Illig L
    Hautarzt; 1967 Jul; 18(7):293-8 contd. PubMed ID: 5598927
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of 4-amidinophenylpyruvic acid on the generalized Sanarelli-Shwartzman phenomenon].
    Kleking GP; Meerbakh B
    Farmakol Toksikol; 1976; 39(5):609-12. PubMed ID: 1028590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the location of the thrombocytes disappearing from the blood in generalized Shwartzman-Sanarelli phenomenon].
    Rotter W; Göing H; Günther G; Schulz E
    Verh Dtsch Ges Pathol; 1967; 51():267-70. PubMed ID: 4175816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.